The impact would be major. In fact, not only would it cause an earthquake in Quebec's insurance community, but it would also impact the value proposition of employers to employees.
For many employers, the drug benefits they offer set them apart from their competitors. This would have an impact on their ability to compete. Many people in the business community are asking a lot of questions. I would say that our working committee on the issue is one of the most active, along with the life sciences committee, because it's also a sector that needs to be protected in Canada.
Those who live in Montreal, including Mr. Scarpaleggia, may recall that there used to be a thriving pharmaceutical industry on Highway 40 and that now many of those companies have moved to Mississauga.
That's good for the chair.
All in all, the pharmaceutical market in Quebec calls for the utmost vigilance. The implementation of a drug insurance plan will therefore have to be done in collaboration with the partners.